Abstract
Background Hazardous pathogens are spread in either droplets or aerosols produced during aerosol generating procedures (AGP). Adjuncts minimising exposure of healthcare workers to hazardous pathogens released during AGP may be beneficial. We used state-of-the-art Computational Fluid Dynamics modelling to optimise the performance of a custom-designed shield.
Methods We modelled airflow patterns and trajectories of particles (size range 1–500µm) emitted during a typical cough using Computational Fluid Dynamics (ANSYS Fluent software), in the presence and absence of a protective shield enclosing the head of a patient. We modelled the effect of different shield designs, suction tube position, and suction flow rate on particle escape from the shield.
Results Use of the shield prevented escape of 99.1–100% of particles, which were either trapped on the shield walls (16–21%) or extracted via suction (79–82%). At most, 0.9% particles remained floating inside the shield. Suction flow rates (40–160L min−1) had no effect on the final location of particles in a closed system. Particle removal from within the shield was optimal when a suction catheter was placed vertically next to the head of the patient. Addition of multiple openings in the shield reduced the purging performance from 99% at 160 L min−1 to 67% at 40 L min−1.
Conclusion Computational fluid dynamics modelling provides information to guide optimisation of the efficient removal of hazardous pathogens released during AGP from a custom-designed shield. These data are essential to establish before clinical use and/or pragmatic clinical trials.
Competing Interest Statement
Designers/Patent holders: PP/IR
Funding Statement
Innovate UK provided funding for the design and production of the Shield. Arup undertook the study gratis
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Nil
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data is available online.
http://www.the-mtc.org/news-items/intubation-shield-supporting-our-frontline-nhs-workers